5-MeO-MiPT is a synthetic psychedelic and entactogenic substance of the tryptamine class. Its synthesis and human psychopharmacology were first published by Shulgin, Repke, and colleagues in 1985, with further documentation in Shulgin's 1997 book TiHKAL. The substance is characterized by its notably stimulating and body-oriented effects, including pronounced tactile and sexual enhancement, while generally producing fewer visual distortions than typical psychedelics. It is almost exclusively obtained as a research chemical through online vendors.
Also known as: Moxy, 5‑methoxy‑N‑methyl‑N‑isopropyltryptamine, N‑isopropyl‑5‑methoxy‑N‑methyltryptamine
Classification
Chemical: Tryptamine
Psychoactive: Entactogen
Psychoactive: Psychedelic
Tag: Common
Tag: Empathogen
Tag: Indole alkaloid
Tag: Research-Chemical
Tag: substituted tryptamine
Effects
Spontaneous Tactile Sensations
Stimulation And Sedation
Nausea
Mentalphysical Stimulation
Decreased Appetite
Pupil Dilation
Introspection
Time Distortion
Conceptual Thinking
Ego Suppression Loss And Death
Enhanced Pattern Recognition
Euphoria
Auditory Enhancements
Auditory Distortion
Auditory Hallucination
Visual Drifting
Tracers
After Images
Routes of Administration
Oral
Dosage
Heavy: 15+ mg
Light: 2 – 5 mg
Common: 5 – 10 mg
Strong: 10 – 15 mg
Threshold: 0.5-1 mg
Duration
Onset: 0.25-0.67 h
Comeup: 0.25-1 h
Peak: 2-3 h
Offset: 2-3 h
After Effects: 2-4 h
Total Duration: 4-7 h
Inhaled
Dosage
Heavy: 15 mg
Light: 2 – 5 mg
Common: 5 – 10 mg
Strong: 10 – 15 mg
Threshold: 2 mg
Duration
Onset: 0.33-1 h
Comeup: 0.33-1 h
Peak: 1-2 h
Offset: 1-2 h
After Effects: 1-3 h
Smoked
Dosage
Heavy: 20+ mg
Light: 5 – 10 mg
Common: 10 – 15 mg
Strong: 15 – 20 mg
Threshold: 5 mg
Duration
Onset: 0.33-1 h
Comeup: 0.5-0.75 h
Peak: 0.02-0.5 h
Offset: 0.5-4 h
After Effects: 1-3 h
Total Duration: 2-7 h
Insufflated
Dosage
Heavy: 15 mg
Light: 2 – 4 mg
Common: 4 – 10 mg
Duration
Onset: 0.25-0.5 h
After Effects: 2-4 h
Sublingual
Dosage
Heavy: 12+ mg
Light: 2–4 mg
Common: 4–6 mg
Strong: 6–10 mg
Threshold: 1–2 mg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
5-MeO-MiPT - Guía de sustancias de DrugsPRO
5-MeO-MiPT: 5-MeO-MiPT is a synthetic psychedelic and entactogenic substance of the tryptamine class. Its synthesis and human psychopharmacology were first published by Shulgin, Repke, and colleagues in 1985, with further documentation in Shulgin's 1997 book TiHKAL. The substance is characterized by
